Premium
Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia
Publication year - 2021
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/ejh.13575
Subject(s) - blinatumomab , minimal residual disease , medicine , residual , pediatrics , lymphoblastic leukemia , library science , computer science , algorithm , leukemia